SEC Form 4 · accession 0001209191-18-047057
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wilhelmus Cm Groenhuysen
Officer — Chief Financial Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 16, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 14, 2018 | S | 100 | $37.85 | D | 108,118 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 400 | $37.90 | D | 107,718 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 200 | $38.00 | D | 107,518 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 68 | $37.80 | D | 107,450 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 200 | $37.70 | D | 107,250 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 500 | $37.75 | D | 106,750 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 200 | $37.55 | D | 106,550 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 300 | $37.65 | D | 106,250 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 100 | $37.60 | D | 106,150 | D | |
| Ordinary SharesF1 | Aug 14, 2018 | S | 2,300 | $37.50 | D | 103,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.